Introducing Galleri multi-cancer early detection test

Galleri is a proactive blood test that can be done annually, screening for many aggressive cancers before symptoms appear.1,2,3

Request Galleri
Already have an account? Log In

Galleri is available by prescription only. The Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur. The Galleri test should be used in addition to healthcare provider recommended screening tests.

illustrated video poster of the Galleri test sitting on a table in an examination room with an anatomy poster on the wall behind it

Galleri is available by prescription only. The Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur. The Galleri test should be used in addition to healthcare provider recommended screening tests.

Who is eligible?

The Galleri test is available as a covered benefit to eligible associates, spouses and retirees enrolled in a Bimbo Bakeries USA medical plan who meet the following eligibility criteria:

Associates, Spouses4

  • Enrolled in a Bimbo Bakeries USA medical plan
  • 50 years and older
  • 40-49 years old with the risk factors documented below
  • 40-49 years old AND at least one of the following risk factors:
    • Cancer survivor who has completed treatment at least 5 years ago*
    • Currently smokes or quit smoking less than 10 years ago
    • Diagnosis of cirrhosis or chronic Hepatitis B or C infection
    • Infection with certain strains of HPV (e.g. HPV 16 or 18)
    • Known hereditary cancer syndrome
      • Confirmation or documentation of a gene mutation associated with increased cancer risk (e.g., Li-Fraumeni syndrome, Hereditary Breast and Ovarian Cancer syndrome [BRCA1/2], Lynch syndrome, and CHEK2).
  • 40-49 years old AND at least two of the following risk factors:
    • Documented genetic predisposition (germline variant)
    • First degree relative with cancer**
    • History of HIV infection
    • Current use of immunosuppressive therapies after solid organ transplant
    • Diabetes
    • BMI:
      • Female ≥ 30 kg/m2
      • Male ≥ 35 kg/m2

* excludes basal or squamous cell carcinoma of the skin

** excludes basal or squamous cell carcinoma of the skin and/or the second cancer is not a recurrence or metastasis

Please note that the Galleri test is not available for people who are currently pregnant.

woman with brown hair wearing a tan sweater and gray pants smiling softly and sitting on a chair in her living room

Retirees4

  • Enrolled in a Bimbo Bakeries USA medical plan
  • 50 years and older
  • 40-49 years old with the risk factors documented below
  • 40-49 years old AND at least one of the following risk factors:
    • Cancer survivor who has completed treatment at least 5 years ago*
    • Currently smokes or quit smoking less than 10 years ago
    • Diagnosis of cirrhosis or chronic Hepatitis B or C infection
    • Infection with certain strains of HPV (e.g. HPV 16 or 18)
    • Known hereditary cancer syndrome
      • Confirmation or documentation of a gene mutation associated with increased cancer risk (e.g., Li-Fraumeni syndrome, Hereditary Breast and Ovarian Cancer syndrome [BRCA1/2], Lynch syndrome, and CHEK2).
  • 40-49 years old AND at least two of the following risk factors:
    • Documented genetic predisposition (germline variant)
    • First degree relative with cancer**
    • History of HIV infection
    • Current use of immunosuppressive therapies after solid organ transplant
    • Diabetes
    • BMI:
      • Female ≥ 30 kg/m2
      • Male ≥ 35 kg/m2

* excludes basal or squamous cell carcinoma of the skin

** excludes basal or squamous cell carcinoma of the skin and/or the second cancer is not a recurrence or metastasis

Please note that the Galleri test is not available for people who are currently pregnant.

Black couple sitting at their kitchen table writing on a notepad with a cup of coffee and a tablet on the table in front of them
Already have an account? Log In

While individuals ages 40-49 with certain risk factors may be at an elevated risk for cancer, Galleri was only studied in a population age 50 and older.5

Galleri for Bimbo Bakeries USA

The Galleri test is offered as a covered benefit to eligible associates, spouses and retirees enrolled in a Bimbo Bakeries USA medical plan.

To request the test you will need an Access ID. 

For associates and spouses, your Access ID is the Oracle employee ID number. This can be found on Bimbo Bakeries USA associates paychecks or in the Associate Self Service portal.

For retirees, your Access ID is your zip code and date of birth. This is a total of 13 digits. For example: Zip Code: 12345 Date of Birth 01/01/1950 – the Access ID would be 1234501011950

Please use your personal email address when requesting the test.

Eligible individuals can request the test once every 12 months from the time of blood draw.

Screen for more in 4 simple steps

illustrated graphic of a Black male doctor in a white lab coat reading a chart

Request the test

It will take about 10 minutes to complete an online health questionnaire about your medical history. The Galleri test, by GRAIL, is available by prescription only. By requesting the test and completing the questionnaire, you’re requesting a prescription from Recuro Health, an independent telemedicine provider.

illustrated graphic of the Galleri test box sitting on a table in front of a window

Receive a collection kit

If the Recuro Health telemedicine provider confirms your eligibility and prescribes the Galleri test, you will receive a notification via email and a collection kit in the mail. Visit Galleri.com/schedule to book your blood draw appointment at a GRAIL blood draw partner.

illustrated graphic of a white, gray haired female patient having her blood drawn

Provide your sample

Bring your test kit and Test Requisition Form (TRF) with you to the appointment. A trained technician will draw your blood sample and ship the kit to the GRAIL lab.

Illustrated graphic of a black man sitting in a blue armchair and reviewing test results on a tablet

Receive your results

Recuro Health will contact you when your result is ready — about 2-3 weeks after your blood is received at the GRAIL lab.

Already have an account? Log in

Cancer screening with Galleri can make a difference

Galleri looks for many deadly cancers before symptoms appear from a single blood draw and identifies a unique “fingerprint” of 50+ cancers, including many without a recommended screening available today.
  • Jackie

    Patient testimonial: Jackie

    Cancer Signal Detected
    Read Jackie's full story

  • Cindy testimonial preview

    Patient testimonial: Cindy

    Cancer Signal Detected

  • Jonathan Testimonial Lyphoma

    Patient testimonial: Jonathan

    Cancer Signal Detected

  • Rich testimonials

    Patient testimonial: Rich

    Cancer Signal Detected

  • Mary patient vid

    Patient testimonial: Mary

    Cancer Signal Detected

  • Roger testimonial

    Patient testimonial: Roger

    Cancer Signal Detected

  • Valerie

    Patient testimonial: Valerie

    Cancer Signal Detected

  • Patient story video still closeup of Tami

    Patient testimonial: Tami

    No Cancer Signal Detected

  • patient story video still of Keith and his wife on a walk

    Patient testimonial: Keith

    No Cancer Signal Detected

  • Jennifer Testimonial poster

    Patient testimonial: Jennifer

    No Cancer Signal Detected
    Read Jennifer's full story

  • Rich S Taci

    Patient testimonial: Rich & Staci

    Cancer Signal Detected
    Read Rich & Staci's full story

  • Oncologist perspective

    Oncologist Perspectives

1 / 12

Frequently Asked Questions for Bimbo Bakeries USA 

Additional Frequently Asked Questions about the Galleri test

The Galleri Test is available as a covered benefit to eligible associates, spouses and retirees enrolled in a Bimbo Bakeries USA medical plan who are aged 50 and older or aged 40-49 with elevated risk factors as documented above.

To access the Galleri test as a covered benefit, you must request the test through this webpage. 

When requesting through this website, an independent telemedicine healthcare provider will review your request and order the test if appropriate. The test is available by prescription only.

The cost of the Galleri test, blood draw, and laboratory fees are all covered under this benefit at no cost to eligible retirees, associates and spouses.

An at-home or in-lab blood draw is included in the price of the test if scheduled with one of our partner labs. Find a time and location convenient for you at Galleri.com/schedule.

When requesting the Galleri test you will need to provide an Access ID to confirm eligibility for the benefit. 

For associates and spouses, your Access ID is the Oracle employee ID number. This can be found on Bimbo Bakeries USA associates paychecks or in the Associate Self Service portal.

For retirees, your Access ID is your zip code and date of birth. This is a total of 13 digits. For example: Zip Code: 12345 Date of Birth 01/01/1950 – the Access ID would be 1234501011950

Under the Bimbo Bakeries USA benefit program, associates, spouses and retirees are eligible for benefit coverage of the Galleri test every 12 months.

To access the Galleri test as a covered benefit, you must request the test through this web page. An independent telemedicine provider will review your request and order the test, if appropriate.

The Galleri test is provided at no cost to eligible retirees, associates and spouses only when obtained through this authorized site https://www.Galleri.com/BimboBakeries.

The blood draw associated with Galleri must occur on a date you are covered under this employee benefit.

Employees are responsible for the full cost of the test when obtained via any other means such as a personal physician or when the blood draw date of service occurs after Bimbo Bakeries USA benefit coverage has ended.

Get support

For questions about the Galleri test, please contact GRAIL Customer Service:

The Galleri test is recommended for use in adults with an elevated risk for cancer, such as those age 50 or older. The test does not detect all cancers and should be used in addition to routine cancer screening tests recommended by a healthcare provider. The Galleri test is intended to detect cancer signals and predict where in the body the cancer signal is located. Use of the test is not recommended in individuals who are pregnant, 21 years old or younger, or undergoing active cancer treatment.

Results should be interpreted by a healthcare provider in the context of medical history, clinical signs, and symptoms. A test result of No Cancer Signal Detected does not rule out cancer. A test result of Cancer Signal Detected requires confirmatory diagnostic evaluation by medically established procedures (e.g., imaging) to confirm cancer.

If cancer is not confirmed with further testing, it could mean that cancer is not present or testing was insufficient to detect cancer, including due to the cancer being located in a different part of the body. False positive (a cancer signal detected when cancer is not present) and false negative (a cancer signal not detected when cancer is present) test results do occur. Rx only.

The GRAIL clinical laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and accredited by the College of American Pathologists. The Galleri test was developed — and its performance characteristics were determined — by GRAIL. The Galleri test has not been cleared or approved by the Food and Drug Administration. The GRAIL clinical laboratory is regulated under CLIA to perform high-complexity testing. The Galleri test is intended for clinical purposes

  1. US Preventive Services Task Force. A,B,C grade recommendations, cancer, screenings. [cited 2023 Oct 23]. https://www.uspreventiveservicestaskforce.org/uspstf/topic_search_results
  2. American Cancer Society Cancer Facts and Figures 2023. Available at: https://www.cancer.org/content/... GRAIL, Inc. Data on file GA-2021-0065
  3. Klein EA, Richards D, Cohn A, et al. Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set. Ann Oncol. 2021 Sep;32(9):1167-77. doi: 10.1016/j.annonc.2021.05.806
  4. Christine Clark Dur, Margaret McCusker. Evaluation of factors associated with elevated cancer risk among persons under age 50. GRAIL, LLC. Data on File GR-2023-0098
  5. Schrag D, Beer TM, McDonnell CH, et al. Blood-based tests for multi-cancer early detection (PATHFINDER): a prospective cohort study. Lancet. 2023;402:1251-1260. doi:10.1016/S0140-6736(23)01700-2
  6. Liu MC, Oxnard GR, Klein EA, et al. Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA. Ann Oncol. 2020 Mar 30;31(6):745-59. doi: 10.1016/j.annonc.2020.02.011
  7. Thierry AR, El Messaoudi S, Gahan PB, et al. Origins, structures, and functions of circulating DNA in oncology. Cancer Metastasis Rev. 2016 Jul 8;35:347–76. doi: 10.1007/s10555-016-9629-x
  8. American Cancer Society. Lifetime risk of developing or dying from cancer. [cited 2023 Oct 11]. https://www.cancer.org/cancer/cancer-basics/lifetime-probability-of-developingor- dying-from-cancer.html
  9. Surveillance, Epidemiology, and End Results (SEER) Program SEER*Stat Database: Incidence - SEER Research Limited-Field Data, 21 Regs, 2020 Nov Sub (2000-2018) - Linked To County Attributes - Time Dependent (1990-2018) Income/Rurality, 1969-2019 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released 2021 Apr, based on the 2020 Nov submission. [Risk Factor Data on file: American Cancer Society Cancer Prevention Studies II/III.]
  10. NIH, National Cancer Institute. Genetic testing for inherited cancer susceptibility syndromes. [cited 2023 Mar 3]. https://www.cancer.gov/about-cancer/causesprevention/ genetics/genetic-testing-fact-sheet